Literature DB >> 8651228

Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators.

M Cushman1, D Yanez, B M Psaty, L P Fried, G Heiss, M Lee, J F Polak, P J Savage, R P Tracy.   

Abstract

The cross-sectional correlates of three hemostatic factors--fibrinogen, factor VII, and factor VIII--were examined in the Cardiovascular Health Study, a population-based cohort study of 5,201 subjects over age 65 years. Subjects were recruited in 1989-1990 in Forsyth County, North Carolina; Sacramento County, California; Washington County, Maryland; and Pittsburgh, Pennsylvania. In multivariate linear regression models, cardiac risk factors significantly associated with fibrinogen were current smoking, race, lipids, and white blood count. In women, alcohol use, obesity, physical activity, and insulin level were also significant, while in men hypertension was correlated. The significant correlates of factor VII were lipids and white blood count in men and estrogen use, alcohol use, race, lipids, insulin level, white blood count, and obesity in women. The independent correlates of factor VIII were insulin, glucose, and race in both sexes; low density lipoprotein cholesterol, white blood count, and diuretic use in men; and alcohol use in women. In multivariate models, factors known to be modifiable risk factors for cardiovascular disease accounted for more of the population variance of these hemostatic factors in women than in men, especially for factor VII. The hemostatic factors may mediate some effects of risk factors on disease, and this should be considered in longitudinal studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651228     DOI: 10.1093/oxfordjournals.aje.a008799

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  24 in total

1.  A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Authors:  Kevin R Viel; Deepa K Machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan C Souto; Juan M Peralta; Todd Smith; John Blangero; Sandra Porter; Stephen T Warren; Jordi Fontcuberta; Jose M Soria; W Dana Flanders; Laura Almasy; Tom E Howard
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

Review 2.  Inflammation, coagulation, and the pathway to frailty.

Authors:  Bindu Kanapuru; William B Ershler
Journal:  Am J Med       Date:  2009-07       Impact factor: 4.965

3.  Obesity paradox in the era of percutaneous coronary intervention with 2nd-generation drug-eluting stents: an analysis of a multicenter PCI registry.

Authors:  Daisuke Ueshima; Shunji Yoshikawa; Taro Sasaoka; Yu Hatano; Ken Kurihara; Yasuhiro Maejima; Mitsuaki Isobe; Takashi Ashikaga
Journal:  Heart Vessels       Date:  2018-07-31       Impact factor: 2.037

4.  Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.

Authors:  Danyelle R A Rios; Ana Paula Fernandes; Roberta C Figueiredo; Daniela A M Guimarães; Cláudia N Ferreira; Ana C Simões E Silva; Maria G Carvalho; Karina B Gomes; Luci Maria Sant' Ana Dusse
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

5.  Relationship between platelet phospholipid FA and mean platelet volume in healthy men.

Authors:  Duo Li; Alan Turner; Andrew J Sinclair
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

Review 6.  Obesity and eye diseases.

Authors:  Ning Cheung; Tien Y Wong
Journal:  Surv Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 6.048

7.  Fibrinogen stimulates in vitro angiogenesis by choroidal endothelial cells via autocrine VEGF.

Authors:  Satomi Shiose; Yasuaki Hata; Yoshihiro Noda; Yukio Sassa; Atsunobu Takeda; Hiroshi Yoshikawa; Kimihiko Fujisawa; Toshiaki Kubota; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

8.  Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.

Authors:  N C Olson; L M Raffield; L A Lange; E M Lange; W T Longstreth; G Chauhan; S Debette; S Seshadri; A P Reiner; R P Tracy
Journal:  J Thromb Haemost       Date:  2017-12-08       Impact factor: 5.824

9.  Prevalence of thrombophilias in patients presenting for bariatric surgery.

Authors:  D Wayne Overby; Geoffrey P Kohn; Mitchell A Cahan; Joseph A Galanko; Karen Colton; Stephan Moll; Timothy M Farrell
Journal:  Obes Surg       Date:  2009-07-05       Impact factor: 4.129

10.  Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort.

Authors:  Jared D Sturgeon; Aaron R Folsom; W T Longstreth; Eyal Shahar; Wayne D Rosamond; Mary Cushman
Journal:  Stroke       Date:  2008-06-05       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.